Filana Therapeutics (SAVA) Q4 2022 Earnings

28FebConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.56
-0.51
-0.46
-0.41

Details

Expected EPS
-0.56
Actual EPS
-0.47
Surprise EPS
0.09
Surprise Percent
+16.07%

Description

Filana Therapeutics (SAVA) has reported earnings of -0.47 per share for Q4 2022.

0 Comments

Share your thoughts